EFFECT OF PLAZEPOD VERSUS ELECTRICAL STIMULATION ON RISK OF FALLING IN HEMODIALYSIS PATIENTS
HD Fall Risk
1 other identifier
interventional
60
1 country
1
Brief Summary
Renal nutrition Fluid control Safe physical activity Sleep hygiene, energy and managing fatigue Adherence and awareness
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
February 2, 2026
CompletedStudy Start
First participant enrolled
March 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 22, 2027
February 2, 2026
January 1, 2026
9 months
January 15, 2026
January 23, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Risk of Falling Assessed by Timed Up and Go Test (TUG)
Change in risk of falling measured using the Timed Up and Go (TUG) test, recorded in seconds. Lower scores indicate better functional mobility and reduced fall risk.
Baseline and after 12 weeks of intervention
Balance Performance Assessed by Berg Balance Scale (BBS)
Change in static and dynamic balance measured using the Berg Balance Scale (BBS), scored from 0 to 56 points, with higher scores indicating better balance performance.
Baseline and after 12 weeks
Lower Limb Muscle Strength
Change in lower limb muscle strength measured using a hand-held dynamometer, recorded in kilograms (kg).
Baseline and after 12 weeks
Secondary Outcomes (2)
Physical Activity Level
Baseline and after 12 weeks
Kidney Disease-Related Quality of Life
Baseline and after 12 weeks
Other Outcomes (1)
Adherence to Intervention Program
Throughout the 12-week intervention period
Study Arms (2)
BlazePod Training plus Lifestyle Education
EXPERIMENTALParticipants in this arm will receive an interactive sensorimotor training program using the BlazePod system combined with a structured lifestyle education program. BlazePod training will focus on improving balance, reaction time, coordination, and functional mobility through static and dynamic balance tasks, reactive stepping, and lower-limb coordination exercises. Training sessions will be conducted three times per week for 30 minutes over a period of 12 weeks under the supervision of a physical therapist. In addition, participants will attend a weekly lifestyle education session addressing renal nutrition, fluid management, safe physical activity, fall prevention strategies, sleep hygiene, fatigue management, and medication adherence.
Tens plus Lifestyle Education
ACTIVE COMPARATORParticipants in this arm will receive neuromuscular electrical stimulation (NMES) applied to the lower limb muscles, including bilateral quadriceps and hamstrings, combined with the same structured lifestyle education program as the experimental group. NMES will be delivered using a portable electrical stimulation device with parameters adjusted to produce visible and comfortable muscle contractions. Sessions will be conducted three times per week for 30 minutes over 12 weeks under physical therapist supervision. Lifestyle education sessions will be provided once weekly and will include renal nutrition, fluid control, safe physical activity, fall prevention strategies, sleep hygiene, fatigue management, and medication adherence.
Interventions
This intervention consists of interactive sensorimotor training using the BlazePod system, a visual stimulus-based device designed to improve balance, coordination, reaction time, and functional mobility. Participants will perform static and dynamic balance exercises, reactive stepping drills, lower-limb coordination tasks, and dual-task activities in response to visual cues emitted by the BlazePod sensors. Training sessions will be conducted three times per week, with each session lasting 30 minutes, over a total duration of 12 weeks. All sessions will be supervised by a licensed physical therapist to ensure safety and appropriate progression of exercise difficulty. The intervention aims to reduce fall risk by enhancing neuromuscular control and postural stability in hemodialysis patients.
This intervention involves the application of neuromuscular electrical stimulation to the lower limb muscles, specifically the bilateral quadriceps and hamstrings, using a portable electrical stimulation device. Surface electrodes will be placed over the motor points to elicit visible and comfortable muscle contractions. Stimulation parameters will include a frequency of 35-50 Hz, pulse width of 200-400 microseconds, and a duty cycle of 10 seconds on and 30 seconds off. Sessions will be administered three times per week for 30 minutes over 12 weeks under the supervision of a physical therapist. The intervention aims to improve muscle strength, balance, functional mobility, and reduce fall risk in hemodialysis patients.
Eligibility Criteria
You may qualify if:
- Male patients aged 40 to 50 years.
- Diagnosed with end-stage renal disease and receiving maintenance hemodialysis for at least 6 months.
- Medically stable and cleared by a nephrologist to participate in physical activity and/or electrical stimulation.
- Able to ambulate independently or with minimal assistance.
- Cognitively able to understand study procedures.
- Not participating in any other structured exercise program.
You may not qualify if:
- Severe neurological or orthopedic disorders affecting mobility.
- Unstable cardiovascular conditions.
- Cognitive impairment or sensory deficits.
- Contraindications to neuromuscular electrical stimulation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Tanta
Tanta, Alquarbia, 31111, Egypt
Related Links
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Application of PlazePod Device and Electrical Stimulation for 60 patients each group 30 for 3months for 40-50age Additionally life style education program, such as: Renal nutrition Fluid control Safe physical activity Sleep hygiene, energy and managing fatigue Adherence and awareness For 3 months, there was one session every week, lasting 30 minutes
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- EFFECT OF PLAZEPOD VERSUS ELECTRICAL STIMULATION ON RISK OF FALLING IN HEMODIALYSIS PATIENTS
Study Record Dates
First Submitted
January 15, 2026
First Posted
February 2, 2026
Study Start
March 21, 2026
Primary Completion (Estimated)
December 22, 2026
Study Completion (Estimated)
March 22, 2027
Last Updated
February 2, 2026
Record last verified: 2026-01